|
September 19, 2008
(Friday) |
|
|
|
|
|
|
|||||
|
|
19:50 |
- |
|
|
OPENING CEREMONIES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 20, 2008
(Saturday) |
|
|
|
|
|
|
|||||
|
AM SESSION |
|
JOINT PLENARY
SESSION - Chinese Cancer Congress / |
|||||||||
|
|
Start time |
- |
End time |
|
Presentation |
Speaker |
Affiliation |
|
|
|
|
|
|
8:00 |
- |
8:40 |
|
Plenary Session
Address |
Zhu Chen |
Minister of Health
in |
|
|
|
|
|
|
8:40 |
- |
9:20 |
|
Reducing the burden
of cancer in populations through behavior change and public policy |
David Hill |
Professor &
Director, The Cancer Council |
|
|
|
|
|
|
9:20 |
- |
10:00 |
|
Personalized Therapy
of Lung Cancer: A Prospective |
Pan-chi Yang |
Dean, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:00 |
- |
10:30 |
|
REFRESHMENT BREAK |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:30 |
- |
11:10 |
|
Molecular Targeted
Therapy of Hematologic Malignancies |
James Griffin |
Chair, Medical
Oncology, Dana Farber Cancer Institute, |
|
|
|
|
|
|
11:10 |
- |
11:50 |
|
Gene Therapy
of Cancer: Promise and Progress |
Nagy Habib |
Professor &
Chair, Dept of Surgery, and Pro-Rector, Imperial College |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11:50 |
- |
13:30 |
|
LUNCH &
NETWORKING |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PM SESSION I |
|
CANCER GENE
THERAPY: HOT TOPICS |
Session
Chairs: Kevin
Scanlon, Depei Liu |
|
CANCER MOLECULAR
TARGETS |
Session
Chairs: Manfred Dietel, Zhigang Dong |
|||||
|
|
Start time |
- |
End time |
|
Presentation |
Speaker |
Affiliation |
|
Presentation |
Speaker |
Affiliation |
|
|
13:30 |
- |
14:00 |
|
Avenue towards
practical point mutation repair with SSO--Replication&transcription
interfering strategies |
Depei Liu |
Professor &
President, |
|
Predictive molecular
pathology - a prerequisite for targeted therapy |
Manfred Dietel |
Director, Institut für Pathologie, Universitätsklinikum
Charité der Humboldt-Universität |
|
|
14:00 |
- |
14:30 |
|
Enhancing
therapeutic index of anticancer drugs with cytochrome
P450 based gene therapy. |
Ling Chen |
Professor and
Director of Guangzhou Institute, |
|
Molecular oncology:
pursuing targets of cancer prevention and therapy |
Zhigang Dong |
Professor &
Director, Hormel Institute, |
|
|
14:30 |
- |
15:00 |
|
p53: a heavily
dictated “dictator” of life and death |
Xin Lu |
Professor &
Director, Ludwig Institute for Cancer Research, |
|
Novel molecular
targets involved in the regulation of epidermal growth factor receptor (EGFR)
in head and neck cancers |
Mahvash Tavassoli |
Professor, Molecular
Oncology, Cancer Gene Therapy Unit, Oral Pathology, |
|
|
15:00 |
- |
15:20 |
||||||||